Merz Aesthetics® Announces Exclusive Partnership With AccuVein, Offering AV500 Vein Visualization Device To Customers in the US

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, and AccuVein, a leader in delivering solutions to increase vein assessment capabilities, today announced an exclusive partnership allowing Merz Aesthetics to be the sole authorized distributor of AccuVein’s vein visualization system in the U.S. aesthetics market.

“We are pleased to add AccuVein’s vein visualization device to the growing portfolio offered by Merz Aesthetics. This agreement enables us to deliver yet another tool that has the potential to evolve the patient experience,” said Patrick Urban, President of Merz Aesthetics North America. “Our commitment to fuel confidence is amplified through partnerships such as this one, and we are excited to continue expanding solutions for our customers to make it easy to work with us.”

AccuVein AV500 uses near-infrared technology to project a vivid map of the vasculature directly on the patient’s skin, revealing the superficial veins, bifurcations, and valves often invisible to the naked eye. In cosmetic injectable procedures, AccuVein helps providers personalize treatment to each patient’s anatomy by locating and avoiding veins, which improves the placement accuracy of injectables, increasing overall patient satisfaction.1,2*

“Patients are demanding a higher standard of care when they seek care from a provider,” said Dr. Tom Hopkins, Chief Medical Officer of AccuVein. “Using AccuVein technology to identify veins, clinicians can significantly enhance the patient experience by using the device that is designed to optimize patient safety in a cost effective manner.”

A limited initial AccuVein field pilot yielded positive results and significant expansion of both new customers and Merz Aesthetics portfolio adoption. Based on the pilot findings, the Merz Aesthetics and AccuVein strategic partnership will now move to scaled national launch.

The AccuVein AV500 device and its accessories are available from Merz Aesthetics and its network of authorized sales representatives. To learn more about the partnership between Merz Aesthetics and AccuVein, visit or contact us at

About Merz Aesthetics
Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients, and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically proven and category-leading, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient’s needs with high standards of safety and efficacy. Being family owned for more than 112 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics’ global headquarters is in Raleigh, N.C., USA, with a commercial presence in 36 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more at

About AccuVein
AccuVein Inc. is the global leader in near infrared (NIR) vein visualization. AccuVein’s flagship product, the AV500, is the only class 1, real-time, laser-based device that uses NIR to help clinicians see a map of superficial veins, valves, and bifurcations on the skin’s surface for better informed venous site selection and accurate needle/catheter placement.  It is built on proprietary technology as embodied in the company’s growing patent portfolio, which currently consists of over 50 issued patents, covering a broad range of imaging and medical diagnostic technologies. AccuVein is in use at more than 5,000 facilities and available for sale in over 130 countries worldwide. To see a demonstration of AccuVein in action, please visit

*  Data accumulated in acute care setting

  1. King, M. The management of bruising following nonsurgical cosmetic treatment. J Clin Aesthet Dermatol. 2017 Feb; 10(2): E1–E4.
  2. Guillon P, Makhloufi M. Prospective evaluation of venous access difficulty and a near-infrared vein visualizer at four French hemophilia treatment centers. Hemophilia. 2014; 1-6.

© 2023 Merz North America, Inc. MERZ AESTHETICS and the MERZ LOGO are trademarks and/or registered trademarks of Merz Pharma GmbH & Co. KGaA in U.S. and/or certain other countries. Third party trademarks and/or registered trademarks are property of their respective owners.

Media Contacts:
Tyra Sitton
Director, North America Communications, Merz Aesthetics
Tel: 984.232.4696

Cheryl Wozniak
Director of Marketing, AccuVein
Tel: 610.401.3214